Cargando…
Effective drugs used to combat SARS-CoV-2 infection and the current status of vaccines
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a causal factor of the coronavirus disease 2019 (COVID-19). Drug repurposing, portraying patented drugs as a successful drug development technique, could shorten the period and minimize costs relative to de novo drug exploration. Recent...
Autores principales: | Awadasseid, Annoor, Wu, Yanling, Tanaka, Yoshimasa, Zhang, Wen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Masson SAS.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7843108/ https://www.ncbi.nlm.nih.gov/pubmed/33550043 http://dx.doi.org/10.1016/j.biopha.2021.111330 |
Ejemplares similares
-
Current advances in the development of SARS-CoV-2 vaccines
por: Awadasseid, Annoor, et al.
Publicado: (2021) -
SARS-CoV-2 variants evolved during the early stage of the pandemic and effects of mutations on adaptation in Wuhan populations
por: Awadasseid, Annoor, et al.
Publicado: (2021) -
Potential protective role of the anti-PD-1 blockade against SARS-CoV-2 infection
por: Awadasseid, Annoor, et al.
Publicado: (2021) -
Initial success in the identification and management of the coronavirus disease 2019 (COVID-19) indicates human-to-human transmission in Wuhan, China
por: Awadasseid, Annoor, et al.
Publicado: (2020) -
New Advances in Canonical Wnt/β-Catenin Signaling in Cancer
por: Wen, Xiaolan, et al.
Publicado: (2020)